Form 4: Immunovant CFO Sells Shares to Cover Tax Obligations

Eva Renee Barnett, CFO of Immunovant, Inc., sold 5,162 shares of common stock to cover tax withholding obligations related to the vesting of restricted stock units.

Summary

• On October 9, 2024, Eva Renee Barnett, the Chief Financial Officer of Immunovant, Inc., sold 5,162 shares of the company's common stock.
• The sale was executed at a weighted average price of $29.56 per share, with individual transactions ranging from $29.28 to $29.85.
• This transaction was to cover tax withholding obligations associated with the vesting of 8,938 restricted stock units (RSUs) on October 4, 2024.
• The sale was mandated by Immunovant's policy requiring tax obligations to be funded through a 'sell to cover' transaction.
• Following the reported transaction, Barnett directly owns 338,614 shares of Immunovant common stock.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (sell to cover taxes) by a company insider. It doesn't indicate any significant positive or negative sentiment.

Industry Context

Form 4 filings are routine disclosures of transactions by company insiders and are a normal part of corporate governance and regulatory compliance.

Stakeholder Impact

• The sale of shares by the CFO could have a minor, temporary impact on the stock price, but it's unlikely to be significant given the reason for the sale.

Key Dates